Real-world weight change among patients treated with glucagon-like peptide-1 receptor agonist, dipeptidyl peptidase-4 inhibitor and sulfonylureas for type 2 diabetes and the influence of medication adherence.

Carls, G S; Tan, R; Zhu, J Y; Tuttle, E; Yee, J; Edelman, S V; Polonsky, W H

Carls, G S; Tan, R; Zhu, J Y; Tuttle, E; Yee, J; Edelman, S V; Polonsky, W H.

Afiliación

Carls GS; Analysis Group, Inc.Menlo Park CA USA.
Tan R; Analysis Group, Inc.Menlo Park CA USA.
Zhu JY; Analysis Group, Inc.Menlo Park CA USA.
Tuttle E; Analysis Group, Inc.Menlo Park CA USA.
Yee J; Intarcia Therapeutics Boston MA USA.
Edelman SV; University of California Oakland CA USA.
Polonsky WH; Taking Control of Your Diabetes Del Mar CA USA.

Obes Sci Pract ; 3(3): 342-351, 2017 09.

Article en En | MEDLINE | ID: mdl-29071110

Palabras clave

Medication adherence; realworld; type 2 diabetes; weight change

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Obes Sci Pract Año: 2017 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google